Hailiang Wei

机构：Affiliated Hospital of Shaanxi University of Chinese Medicine

发表论文 34 篇 · 总被引 490 次 · h-index 13

代表论文

• Xiaojianzhong decoction attenuates gastric mucosal injury by activating the p62/Keap1/Nrf2 signaling pathway to inhibit ferroptosis (2022 · Biomedicine & Pharmacotherapy · 被引 54)
• Treatment of ulcerative colitis with Wu-Mei-Wan by inhibiting intestinal inflammatory response and repairing damaged intestinal mucosa (2022 · Phytomedicine · 被引 54)
• Macrophages as Multifaceted Orchestrators of Tissue Repair: Bridging Inflammation, Regeneration, and Therapeutic Innovation (2025 · Journal of Inflammation Research · 被引 53)
• Wu-Mei-Wan Ameliorates Murine Ulcerative Colitis by Regulating Macrophage Polarization (2022 · Frontiers in Pharmacology · 被引 37)
• CircFAT1 promotes hepatocellular carcinoma progression via miR‐30a‐5p/REEP3 pathway (2020 · Journal of Cellular and Molecular Medicine · 被引 34)
• Long Non-coding RNA SNHG17 Upregulates RFX1 by Sponging miR-3180-3p and Promotes Cellular Function in Hepatocellular Carcinoma (2021 · Frontiers in Genetics · 被引 29)